These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25711199)

  • 1. Image Guided Focal Therapy for Magnetic Resonance Imaging Visible Prostate Cancer: Defining a 3-Dimensional Treatment Margin Based on Magnetic Resonance Imaging Histology Co-Registration Analysis.
    Le Nobin J; Rosenkrantz AB; Villers A; Orczyk C; Deng FM; Melamed J; Mikheev A; Rusinek H; Taneja SS
    J Urol; 2015 Aug; 194(2):364-70. PubMed ID: 25711199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate tumour volumes: evaluation of the agreement between magnetic resonance imaging and histology using novel co-registration software.
    Le Nobin J; Orczyk C; Deng FM; Melamed J; Rusinek H; Taneja SS; Rosenkrantz AB
    BJU Int; 2014 Dec; 114(6b):E105-E112. PubMed ID: 24673731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
    Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
    J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Focal Ablation of Magnetic Resonance Imaging Defined Prostate Cancer Using Magnetic Resonance Imaging Controlled Transurethral Ultrasound Therapy with Prostatectomy as the Reference Standard.
    Ramsay E; Mougenot C; Staruch R; Boyes A; Kazem M; Bronskill M; Foster H; Sugar L; Haider M; Klotz L; Chopra R
    J Urol; 2017 Jan; 197(1):255-261. PubMed ID: 27545572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
    Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
    Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.
    Ghai S; Perlis N; Lindner U; Hlasny E; Haider MA; Finelli A; Zlotta AR; Kulkarni GS; van der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
    Eur Radiol; 2018 Oct; 28(10):4281-4287. PubMed ID: 29696431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology.
    Priester A; Natarajan S; Khoshnoodi P; Margolis DJ; Raman SS; Reiter RE; Huang J; Grundfest W; Marks LS
    J Urol; 2017 Feb; 197(2):320-326. PubMed ID: 27484386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a registration framework to validate MRI with histology for prostate focal therapy.
    Reynolds HM; Williams S; Zhang A; Chakravorty R; Rawlinson D; Ong CS; Esteva M; Mitchell C; Parameswaran B; Finnegan M; Liney G; Haworth A
    Med Phys; 2015 Dec; 42(12):7078-89. PubMed ID: 26632061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.
    Naiki T; Okamura T; Nagata D; Mori Y; Kawai N; Ogawa K; Akita H; Hashimoto Y; Tozawa K; Kohri K
    Asian Pac J Cancer Prev; 2011; 12(4):909-13. PubMed ID: 21790224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.
    Faiena I; Salmasi A; Mendhiratta N; Markovic D; Ahuja P; Hsu W; Elashoff DA; Raman SS; Reiter RE
    J Urol; 2019 Jan; 201(1):91-97. PubMed ID: 30577397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perineural invasion status, Gleason score and number of positive cores in biopsy pathology are predictors of positive surgical margin following laparoscopic radical prostatectomy.
    Yang R; Cao K; Han T; Zhang YF; Zhang GT; Xu LF; Lian HB; Li XG; Guo HQ
    Asian J Androl; 2017; 19(4):468-472. PubMed ID: 27004537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-biopsy 3-Tesla MRI and targeted biopsy of the index prostate cancer: correlation with robot-assisted radical prostatectomy.
    Patel U; Dasgupta P; Challacombe B; Cahill D; Brown C; Patel R; Kirby R
    BJU Int; 2017 Jan; 119(1):82-90. PubMed ID: 27153933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric Magnetic Resonance Imaging Predicts Postoperative Pathology but Misses Aggressive Prostate Cancers as Assessed by Cell Cycle Progression Score.
    Renard-Penna R; Cancel-Tassin G; Comperat E; Varinot J; Léon P; Roupret M; Mozer P; Vaessen C; Lucidarme O; Bitker MO; Cussenot O
    J Urol; 2015 Dec; 194(6):1617-23. PubMed ID: 26272031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation?
    Cornud F; Khoury G; Bouazza N; Beuvon F; Peyromaure M; Flam T; Zerbib M; Legmann P; Delongchamps NB
    J Urol; 2014 May; 191(5):1272-9. PubMed ID: 24333516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining prostate cancer size and treatment margin for focal therapy: does intralesional heterogeneity impact the performance of multiparametric MRI?
    Aslim EJ; Law YXT; Fook-Chong SMC; Ho HSS; Yuen JSP; Lau WKO; Lee LS; Cheng CWS; Ngo NT; Law YM; Tay KJ
    BJU Int; 2021 Aug; 128(2):178-186. PubMed ID: 33539650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.
    Faiena I; Salmasi A; Mendhiratta N; Markovic D; Ahuja P; Hsu W; Elashoff DA; Raman SS; Reiter RE
    J Urol; 2019 Jan; 201(1):91-97. PubMed ID: 30142318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
    Eggener SE; Yousuf A; Watson S; Wang S; Oto A
    J Urol; 2016 Dec; 196(6):1670-1675. PubMed ID: 27449263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor volume in radical prostatectomy specimens assessed by digital image analysis software correlates with other prognostic factors.
    Sherwin JC; Mirmilstein G; Pedersen J; Lawrentschuk N; Bolton D; Mills J
    J Urol; 2010 May; 183(5):1808-14. PubMed ID: 20303103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.